Alessia Casamassa
San Giovanni Rotondo, 71013, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Study of POLR3A variants in a family trio suggests mutation-specific pathogenetic mechanisms: insights from integrative OMIC approaches.
Journal: Cell communication and signaling : CCS
Published: October 13, 2025
Investigating the Impact of the Parkinson's-Associated GBA1 E326K Mutation on β-Glucocerebrosidase Dimerization and Interactome Dynamics Through an In Silico Approach.
Journal: International journal of molecular sciences
Published: September 13, 2024
Production of an induced pluripotent stem cell line CSSi018-A (14192) from a patient with hypomyelinating leukodystrophy 7 (HLD7) carrying biallelic variants of POLR3A (c.1802 T > A; c.4072G > A).
Journal: Stem cell research
Published: May 27, 2024
Structural and functional alterations of neurons derived from sporadic Alzheimer's disease hiPSCs are associated with downregulation of the LIMK1-cofilin axis.
Journal: Alzheimer's research & therapy
Published: April 11, 2024
Corrigendum: Deepening the understanding of CNVs on chromosome 15q11-13 by using hiPSCs: An overview.
Journal: Frontiers in cell and developmental biology
Published: January 10, 2023
Circadian profile, daytime activity, and the Parkinson's phenotype: A motion sensor pilot study with neurobiological underpinnings.
Journal: Neurobiology of sleep and circadian rhythms
Published: December 16, 2022
Deepening the understanding of CNVs on chromosome 15q11-13 by using hiPSCs: An overview.
Journal: Frontiers in cell and developmental biology
Published: November 25, 2022
Generation of an induced pluripotent stem cells line, CSSi014-A 9407, carrying the variant c.479C>T in the human iduronate 2-sulfatase (hIDS) gene.
Journal: Stem cell research
Published: June 12, 2022
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis.
Journal: Journal of neurochemistry
Published: June 24, 2021
Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells.
Journal: International journal of molecular sciences
Published: December 23, 2020
Cerebrospinal fluid and serum d-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease.
Journal: Biochimica et biophysica acta. Proteins and proteomics
Published: August 09, 2020
Last Updated: 09/26/2026